Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H McCabe

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
The American Journal of Cardiology|October 7, 1997
Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial InfarctionC P Cannon, P J Sharis, M J Schweiger, et al.
European Heart Journal|November 1, 2001
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarctionJ Llevadot, R P Giugliano, E M Antman, et al.
Circulation|July 13, 2000
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trialC P Cannon, C H McCabe, R G Wilcox, et al.
European Heart Journal|July 22, 1999
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database studyP H Stone, B Thompson, B L Zaret, et al.
European Heart Journal|June 19, 2002
Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-IIE M Antman, H A Cooper, C M Gibson, et al.
Circulation|January 21, 1997
TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trialC P Cannon, C H McCabe, C M Gibson, et al.
The American Journal of Cardiology|September 8, 2001
Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapyJ A de Lemos, D A Morrow, C M Gibson, et al.
The American Journal of Cardiology|February 1, 1997
Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB)C P Cannon, C H McCabe, P H Stone, et al.
American Heart Journal|June 30, 2000
First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trialsR P Giugliano, C H McCabe, R F Sequeira, et al.
Circulation|February 19, 1998
Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial InfarctionC P Cannon, C H McCabe, S Borzak, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
The American Journal of Cardiology|October 7, 1997
Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial InfarctionC P Cannon, P J Sharis, M J Schweiger, et al.
European Heart Journal|November 1, 2001
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarctionJ Llevadot, R P Giugliano, E M Antman, et al.
Circulation|July 13, 2000
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trialC P Cannon, C H McCabe, R G Wilcox, et al.
European Heart Journal|July 22, 1999
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database studyP H Stone, B Thompson, B L Zaret, et al.
European Heart Journal|June 19, 2002
Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-IIE M Antman, H A Cooper, C M Gibson, et al.
Circulation|January 21, 1997
TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trialC P Cannon, C H McCabe, C M Gibson, et al.
The American Journal of Cardiology|September 8, 2001
Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapyJ A de Lemos, D A Morrow, C M Gibson, et al.
The American Journal of Cardiology|February 1, 1997
Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB)C P Cannon, C H McCabe, P H Stone, et al.
American Heart Journal|June 30, 2000
First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trialsR P Giugliano, C H McCabe, R F Sequeira, et al.
Circulation|February 19, 1998
Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial InfarctionC P Cannon, C H McCabe, S Borzak, et al.
Pageof 10